Elizabeth Cermak's Net Worth
-$107 Thousand
Who is Elizabeth Cermak?
Elizabeth Cermak does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Moleculin Biotech, Inc., SteadyMed Ltd., Clarus Therapeutics Holdings, Inc., and POZEN INC /NC.
SEC CIK
Elizabeth Cermak's CIK is 0001471971
Past Insider Trading and Trends
2022 was Elizabeth Cermak's most active year for acquiring shares with 4 total transactions. Elizabeth Cermak's most active month to acquire stocks was the month of February. 2018 was Elizabeth Cermak's most active year for disposing of shares, totalling 3 transactions. Elizabeth Cermak's most active month to dispose stocks was the month of July. 2011 saw Elizabeth Cermak paying a total of $114,177.00 for 83,000 shares, this is the most they've acquired in one year. In 2011 Elizabeth Cermak cashed out on 3,030 shares for a total of $7,302.30, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Moleculin Biotech, Inc. (MBRX) Snapshot price: $0.49
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SteadyMed Ltd. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Clarus Therapeutics Holdings, Inc. No price found
InvestorElizabeth Cermak owns 5,766 units of Common Stock. In the year 2021 Elizabeth Cermak acquired a total of 5,766 shares in Clarus Therapeutics Holdings, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +50.00% | 1.92K |
—
|
—
| 5.77K |
Jun 7
| |||
Form 4
|
∞
| 3.84K |
—
|
—
| 3.84K |
Dec 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
POZEN INC /NC No price found
EVP, Chief Commercial OfficerElizabeth Cermak owns 20,000 units of Common Stock and 24,970 units of Common Stock ($0.001 par value). From 2009 to 2013 Elizabeth Cermak acquired a total of 89,000 shares in POZEN INC /NC at a cost of $114,177.00, Elizabeth also disposed a total of 3,030 shares of POZEN INC /NC equalling to $7,302.30.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 20K |
—
|
—
| 20K |
Mar 15
| |||
Form 4
|
∞
| 21K |
—
|
—
| 21K |
Oct 25
| |||
Form 4
|
∞
| 10K |
—
|
—
| 10K |
Mar 15
| |||
Form 4
|
∞
| 24.97K |
$2.41 | $60,177.70 | 24.97K |
Oct 1
| |||
Form 4
|
∞
| 10K |
$4.67 | $46,697.00 | 10K |
Mar 14 - Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||